Autolus Therapeutics (AUTL) Financial Statements

Compare

920 Followers

Autolus Therapeutics Financial Overview

Autolus Therapeutics's market cap is currently $322.03M. The company's EPS TTM is $-0.34; its P/E ratio is -1.84; Autolus Therapeutics is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 75.56M	$ 10.12M	$ 1.70M	$ 6.19M	$ 1.51M
Gross Profit	$ -22.05M	$ -130.90M	$ 1.70M	$ 6.19M	$ 1.51M
Operating Income	$ -281.44M	$ -241.43M	$ -179.70M	$ -142.89M	$ -140.37M
EBITDA	$ -281.44M	$ -233.07M	$ -156.77M	$ -132.24M	$ -132.47M
Net Income	$ -287.53M	$ -220.66M	$ -208.38M	$ -148.84M	$ -142.10M
Balance Sheet
Cash & Short-Term Investments	$ 300.71M	$ 588.02M	$ 239.57M	$ 382.44M	$ 310.34M
Total Assets	$ 589.07M	$ 782.73M	$ 375.38M	$ 490.27M	$ 405.56M
Total Debt	$ 71.39M	$ 52.63M	$ 52.97M	$ 24.26M	$ 68.01M
Net Debt	$ -32.74M	$ -174.75M	$ -186.60M	$ -358.18M	$ -242.32M
Total Liabilities	$ 410.94M	$ 355.40M	$ 263.91M	$ 191.60M	$ 92.24M
Stockholders' Equity	$ 178.13M	$ 427.32M	$ 111.47M	$ 298.67M	$ 313.32M
Cash Flow
Free Cash Flow	$ -303.32M	$ -241.09M	$ -156.57M	$ -123.15M	$ -126.72M
Operating Cash Flow	$ -283.57M	$ -206.27M	$ -145.59M	$ -112.31M	$ -117.86M
Investing Cash Flow	$ 158.46M	$ -394.55M	$ -10.99M	$ -10.84M	$ -8.86M
Financing Cash Flow	$ -4.34M	$ 589.55M	$ -883.00K	$ 223.61M	$ 284.06M

Currency in USD

Autolus Therapeutics Earnings and Revenue History

Income Statement >

Autolus Therapeutics Debt to Assets

Balance Sheet >

Autolus Therapeutics Cash Flow

Cash Flow >

Autolus Therapeutics Forecast EPS vs Actual EPS

Earnings >